ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT 2024

GOTHENBURG, Sweden, Jan. 7, 2025 /PRNewswire/ -- Zinzino group revenue increased 34% in Q4 and total revenue for the full year 2024 increased 25%, compared with the previous year. 

The revenue in December for Zinzino's sales markets increased by 59% and amounted to SEK 239.6 (150.3) million. Faun Pharma's external sales increased and amounted to SEK 5.6 (5.1) million. Overall, the Group increased revenues by 58% to SEK 245.2 (155.4) million compared with the previous year.

Sales in Zinzino's sales markets increased by 34% in the fourth quarter of 2024 compared with the same period last year and amounted to SEK 683.0 (509.1) million. Total revenue in the Group increased by 34% in the fourth quarter and amounted to SEK 706.1 (527.9) million.

Accumulated revenue for January – December 2024 increased by 25% to SEK 2200.4 (1766.4) million.

Revenues were distributed as follows:

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information: Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, www.zinzino.com

Pictures for publication free of charge: [email protected]

Certified Adviser: Carnegie Investment Bank AB (publ.)

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-2024,c4088408

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-2024-302344244.html